nach oben

Erschienen in:

01.08.2012 | Original Research Paper

The anti-arthritic and anti-oxidative effect of NBD (6-nitro-1,3-benzodioxane) in adjuvant-induced arthritis (AIA) in rats

verfasst von: Syed Uzair Ali Shah, Nadeem Ashraf, Zahid H. Soomro, Muhammad Raza Shah, Nurul Kabir, Shabana Usman Simjee

Erschienen in: Inflammation Research | Ausgabe 8/2012

Einloggen, um Zugang zu erhalten

Abstract

Objectives

The present study evaluated the anti-arthritic and anti-oxidative effects of 6-nitro-1,3-benzodioxane in the adjuvant-induced arthritis model in rats.

Methods

Arthritis was induced in female rats by intradermal injection of MT37Ra. Arthritis was evaluated by arthritic score, body weight loss, paw volume measurement, and histological changes. The plantar test was used to evaluate the effect of NBD on hyperalgesia.

Results

The hyperalgesia (p < 0.0001) and hind paw inflammation (p < 0.034) was significantly decreased with parallel increase in the body weight of the NBD-treated (25 mg/kg) group compared to arthritic control rats. The antioxidant activity analysis demonstrated that the treatment of NBD significantly suppressed the levels of nitric oxide (p < 0.001) and peroxide (p < 0.002) with a significant increase in the glutathione (p < 0.021) compared to the arthritic control group. Since the IL-1β and TNF-α are key pro-inflammatory cytokines in arthritis, we therefore measured their levels in the serum samples. In comparison to the arthritic control group, the NBD treatment significantly reduced the levels of IL-1β (p < 0.003) and TNF-α (p < 0.026).

Conclusion

Our results suggests that NBD is an anti-arthritic agent that not only reduces the severity of the disease process but also affects contributing factors of arthritic inflammation including free radicals and inflammatory cytokines production.

Firestein GS. Etiology and pathogenesis of rheumatoid arthritis. In: Ruddy S, Harris JED, Sledge CB, Budd RC, Sergent JS, editors. Kelley’s text book of rheumatology, vol. 2. Philadelphia: Saunders; 2001. p. 921–6.

Verbnrgge LM, Patrick DL. Seven chronic conditions: their impact on US adults’ activity levels and use of medical Services. Am J Public Health. 1995;85:173–82.CrossRef

Lard LR, Huizinga TWJ, Hazes JMW, Vliet Vlieland TPM. Delayed referral of female rheumatoid arthritis patients. J Rheumatol. 2001; 28:2190–2.

CDC. Prevalence of doctor-diagnosed arthritis and arthritis-attributable activity limitation—United States, 2007–2009. MMWR. 2010; 59:1261–5.

Feldmann M, Brennan FM, Maini RN. Rheumatoid arthritis. Cell. 1996;85:307.PubMedCrossRef

Nagase H, Woessner JF Jr. Matrix metalloproteinases. J Biol Chem. 1999;274:21491–4.PubMedCrossRef

Brinckerhoff CE, Sporn MB. Retinoids and rexinoids for the 21st century. J Rheumatol. 2003; 30:211–13.

Kaplan JC, Valdez R, Chandrasekaran H, Eibel K, Mikecz TT. Glant and A. Finnegan, Th1 and Th2 cytokines regulate proteoglycan-specific autoantibody isotypes and arthritis. Arthritis Res. 2002;4:545–58.CrossRef

Maini RN, Taylor PC. Anti-cytokines therapy for rheumatoid arthritis. Annu Rev Med. 2000;51:207–29.PubMedCrossRef

10.

Van den berg WB. Anti-cytokine therapy in chronic destructive arthritis. J Arthritis Res. 2001; 3:18–26.

11.

Goronzy JJ, Weyand CM. Thymic function and peripheral T-cell homeostasis in rheumatoid arthritis. Trends Immunol. 2001;22:251–5.PubMedCrossRef

12.

Kohem CL, Brezinschek RI, Wisbey H, Tortorella C, Lipsky PE, Oppenheimer-Marks N. Enrichment of differentiated CD45RBdim, CD27 memory T cells in the peripheral blood, synovial fluid, and synovial tissue of patients with rheumatoid arthritis. Arthritis Rheum. 1996;39:844–54.PubMedCrossRef

13.

Falgarone G, Semerano L, Rullé S, Boissier MC. Targeting lymphocyte activation to treat rheumatoid arthritis. Joint Bone Spine. 2009;76:327–32.PubMedCrossRef

14.

Abreu JR, Grabiec AM, Krausz S, Spijker R, Burakowski T, Maslinski W, et al. The presumed hyporesponsive behavior of rheumatoid arthritis T lymphocytes can be attributed to spontaneous ex vivo apoptosis rather than defects in T cell receptor signaling. J Immunol. 2009;183:621–30.PubMedCrossRef

15.

Vandooren B, Noordenbos T, Ambarus C, Krausz S, Cantaert T, Yeremenko N, et al. Absence of a classically activated macrophage cytokine signature in peripheral spondylarthritis, including psoriatic arthritis. Arthritis Rheum. 2009;60:966–75.PubMedCrossRef

16.

Panayi GS, Lanchbury JS, Kingsley GH. The importance of the T cell in initiating and maintaining the chronic synovitis of rheumatoid arthritis. Arthritis Rheum. 1992;35:729–35.PubMedCrossRef

17.

Szekanecz Z, Koch AE, Kunkel SL, Strieter RM. Cytokines in rheumatoid arthritis: potential targets for pharmacological intervention. Drugs Aging. 1998;12:377–90.PubMedCrossRef

18.

Gravallese EM, Goldring SR. Cellular mechanism and the role of cytokines in erosions in rheumatoid arthritis. Arthritis Rheum. 2000;43:2143–51.PubMedCrossRef

19.

Fan AY, Lao L, Zhang RX, Zhou AN, Wang LB, Moudgil KD, et al. Effects of an acetone extract of Boswellia carterii Birdw. (Burseraceae) gum resin on adjuvant-induced arthritis in lewis rats. J Ethnopharmacol. 2005;101:104–9.PubMedCrossRef

20.

Cai X, Zhou H, Wong YF, Xie Y, Liu ZQ, Jiang ZH, et al. Suppression of the onset and progression of collagen-induced arthritis in rats by QFGJS, a preparation from an anti-arthritic Chinese herbal formula. J Ethnopharmacol. 2007;110:39–48.PubMedCrossRef

21.

Freeman BA, Crapo JD. Biology of disease: free radicals and tissue injury. Lab Invest. 1982; 47:412–26.

22.

Valko M, Leibfritz D, Moncol J, Cronin MT, Mazur M, Telser J. Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol. 2007;39:44–84.PubMedCrossRef

23.

Blake DR, Merry P, Unsworth J, Kidd BL, Outhwaite JM, Ballard R, et al. Hypoxic-reperfusion injury in the inflamed human joint. Lancet. 1989; i:289–93.

24.

Cadenas E. Basic mechanisms of antioxidant activity. BioFactors. 1997;6:391–7.PubMedCrossRef

25.

Heliovaara M, Knekt P, Aho K, Aaran RK, Alfthan G, Aromaa A. Serum antioxidants and risk of rheumatoid arthritis. Ann Rheum Dis. 1994;53:51–3.PubMedCrossRef

26.

Gambhir JK, Lali P, Jain AK. Correlation between blood antioxidant levels and lipid peroxidation in rheumatoid arthritis. Clin Biochem. 1997;30:351–5.PubMedCrossRef

27.

Sakurai H, Kohsaka H, Liu M, Higashiyama H, Hirata Y, Kanno K, et al. Nitric oxide production and inducible nitric oxide synthase expression inflammatory arthritis. J Clin Invest. 1995;96:2357–63.PubMedCrossRef

28.

Wallace JL. Nitric oxide as a regulator of inflammatory processes. Mem Inst Oswaldo Cruz. 2005;100:5–9.PubMedCrossRef

29.

Kizilntuc A, Cogalgil S, Cerrahoglu L. Carnitine and antioxidants levels in patients with rheumatoid arthritis. Scand J Rheumatol. 1998;27:441–5.CrossRef

30.

Hassan MQ, Hadi RA, Al-Rawi ZS, Padron VA, Stohs SJ. The glutathione defense system in the pathogenesis of rheumatoid arthritis. J Appl Toxicol. 2001;21:69–73.PubMedCrossRef

31.

Masella R, Benedetto RD, Vari R, Filesi C, Giovannini C. Novel mechanisms of natural antioxidant compounds in biological systems: Involvement of glutathione and glutathione-related enzymes. J Nutr Biochem. 2005;16:577–86.PubMedCrossRef

32.

Kamanli A, Naziroglu M, Aydilek N, Hacievliyagil C. Plasma lipid peroxidation and antioxidant levels in patients with rheumatoid arthritis. Cell Biochem Funct. 2004;22:53–7.PubMedCrossRef

33.

Los M, Dröge W, Stricker K, Baeuerle PA, Schulze-Osthoff K. Hydrogen peroxide as a potent activator of T lymphocyte functions. Eur J Immunol. 1995;25:159–65.PubMedCrossRef

34.

Tinker AC, Wallace AV. Selective inhibitors of inducible nitric oxide synthase: potential agents for the treatment of inflammatory diseases? Curr Top Med Chem. 2006;6:77–92.PubMedCrossRef

35.

Ali MH, Schlidt SA, Chandel NS, Hynes KL, Schumacker PT, Gewertz BL. Endothelial permeability and IL-6 production during hypoxia: role of ROS in signal transduction. Am J Physiol. 1999;277:L1057–65.PubMed

36.

Chua CC, Hamdy RC, Chua BH. Upregulation of vascular endothelial growth factor by H₂O₂ in rat heart endothelial cells. Free Radic Biol Med. 1998;25(8):891–7.PubMedCrossRef

37.

Simon AR, Rai U, Fanburg BL, Cochran BH. Activation of the JAK-STAT pathway by reactive oxygen species. Am J Physiol. 1998;275:C1640–52.PubMed

38.

Sundaresan M, Yu ZX, Ferrans VJ, Irani K, Finkel T. Requirement for generation of H₂O₂ for platelet-derived growth factor signal transduction. Science. 1995;270:296–9.PubMedCrossRef

39.

Feldmann M, Brennan FM, Maini RN. Role of cytokines in rheumatoid arthritis. Annu Rev Immunol. 1996;14:397–440.PubMedCrossRef

40.

Severn PS, Fraser SG. Bilateral cataracts and glaucoma induced by long-term use of oral prednisolone bough over the internet. Lancet. 2006;368:618.PubMedCrossRef

41.

Biskupiak JE, Brixner DI, Howard KB, Oderda GM. Gastrointestinal complications of over-the-counter nonsteroidal antiinflammatory drugs. J Pain Palliat Care Pharmacother. 2006;20:7–14.PubMedCrossRef

42.

Hinz B, Brune K. Pain and osteoarthritis: new drugs and mechanisms. Curr Opin Rheumatol. 2004;16:628–33.PubMedCrossRef

43.

Schuna AA, Megeff C. New drugs for the treatmentof rheumatoid arthritis. Am J Health Syst Pharm. 2000;57:225–34.PubMed

44.

Meyer-Kirchrath J, Schrör K. Cyclooxygenase-2 inhibition and side-effects of non-steroidal anti-inflammatory drugs in the gastrointestinal tract. Curr Med Chem. 2000;7:1121–9.PubMed

45.

Lester RS, Knowles SR, Shear NH. The risks of systemic corticosteroid use. Dermatol Clin. 1998;16:277–87.PubMed

46.

Lanza FL. Endoscopic studies of gastric and duodenal injury after the use of ibuprofen, aspirin, and other nonsteroidal anti-inflammatory agents. Am J Med. 1984;77:19–24.PubMedCrossRef

47.

Mamdani M, Juurlink DN, Lee DS, et al. Cyclo-oxygenase-2 inhibitors versus non-selective non-steroidal anti-inflammatory drugs and congestive heart failure outcomes in elderly patients: a population based cohort study. Lancet. 2004;363:1751–6.PubMedCrossRef

48.

Santana-Sabagun E, Weisman MH. Nonsteroidal anti-inflammatory drugs. In: Ruddy S, Harris JED, Sledge CB, Budd RC, Sergent JS, editors. Kelly’s textbook of rheumatology, vol. 1. Philadelphia: Saunders; 2001. p. 799–822.

49.

Newman NM, Ling RSM. Acetabular bone destruction related to non-steroidal anti-inflammatory drugs. Lancet. 1985;2:11–4.PubMedCrossRef

50.

Anastassiades T, Chopra R, Law C, Wong E. In vitro suppression of transforming growth factor-b induced stimulation of glycosaminoglycan synthesis by acetylsalicylic acid and its reversal by misoprostol. J Rheumatol. 1998;25:1962–7.PubMed

51.

Satoh Y, Powers C, Toledo LM, Kowalski TJ, Peters PA, et al. Derivatives of 2-[N-(aminocarbonyl)-N-hydroxyamino]methyl]-1,4-benzodioxan as orally active 5-lipoxygenase inhibitors. J Med Chem. 1995;38:68–75.PubMedCrossRef

52.

Manghisi E, Salimbeni A. United States Patents. 1976; Patent number 3969368.

53.

Avakyan AS, Vartanyan SO, Markaryan EA. Biologically active 2-substituted 1,4-benzodioxanes (review). Pharm Chem J. 1988;22:600–11.CrossRef

54.

Labanauskas LK, Brukshtus AB, Gaidelis PG, Udrenaite EB, Daukshas VK. Synthesis and antiinflammatory activity of some new derivatives of 6-benzoyl-1,4-benzodioxane. Pharm Chem J. 1999;33:259–60.CrossRef

55.

Marrs TC, Bright JE, Swanston DW. Acute oral toxicity of 4-dimethylaminophenol to the gastrointestinal tract, liver and kidney of the rat. Arch Toxicol. 1982;50:89–92.PubMedCrossRef

56.

Zimmermann M. Ethical guidelines for investigations of experimental pain in conscious animals. Pain. 1983;16:109–10.PubMedCrossRef

57.

Bakharevski O, Stein-Oakley AN, Thomson NM, Ryan PFJ. Collagen-induced arthritis in rats: contrasting effect of subcutaneous versus intradermal inoculation of type II collagen. J Rheumatol. 1998;25:1945–52.PubMed

58.

Hargreaves K, Dubner R, Brown F, Flores C, Joris J. A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain. 1988;32:77–88.PubMedCrossRef

59.

Brachertz D, Mitchell GF, MacKay IR. Antigen-induced arthritis in mice: induction of arthritis in various strains of mice. Arthritis Rheum. 1977;20:841–50.CrossRef

60.

Bendele A, McAbee T, Sennello G, Frazier J, Chlipala E, McCabe D. Efficacy of sustained levels of interleukin-1 receptor antagonist in animal models of arthritis. Arthritis Rheum. 1999;43:498–506.CrossRef

61.

Glenn EM, Gray J. Adjuvant-induced polyarthritis in rats: biologic and histologic background. Am J Vet Res. 1965;26:1180–94.PubMed

62.

Pearson CM, Wood FD. Studies of arthritis and other lesions induced in rats by the injection of Mycobacterial adjuvant: pathologic details of the arthritis and spondylitis. Am J Pathol. 1963;42:73–95.PubMed

63.

Sluka KA, Willis WD, Westlund KN. The role of dorsal root reflexes in neurogenic inflammation. Pain Forum. 1995;4:141–9.CrossRef

64.

Ghirnikar RS, Lee YL, Eng LF. Inflammation in traumatic brain injury: role of cytokines and chemokines. Neurochem Res. 1998;23:329–40.PubMedCrossRef

65.

Yaksh TL, Hua XY, Kalcheva I, Nozaki-Taguchi N, Marsala M. The spinal biology in humans and animals of pain states generated by persistent small afferent input. Proc Natl Acad Sci USA. 1999;96:7680–6.PubMedCrossRef

66.

McHugh JM, McHugh WB. Pain: neuroanatomy, chemical mediators, and clinical implications. AACN Clin Issues. 2000;11:168–78.PubMedCrossRef

67.

Boddeke EW. Involvement of chemokines in pain. Eur J Pharmacol. 2001;429:115–9.PubMedCrossRef

68.

Ma W, Eisenach JC. Role for both spinal cord COX-1 and COX-2 in maintenance of mechanical hypersensitivity following peripheral nerve injury. Brain Res. 2002;937:94–9.PubMedCrossRef

69.

Goodis HE, Bowles WR, Hargreaves KM. Prostaglandin E2 enhances bradykinin-evoked iCGRP release in bovine dental pulp. J Dent Res. 2000;79:1604–7.PubMedCrossRef

70.

Almeida IC, Camargo MM, Procopio DO, Silva LS, Mehlert A, Travassos LR, et al. Highly purified glycosylphosphatidylinositols from Trypanosoma cruzi are potent proinflammatory agents. EMBO J. 2000;19:1476–85.PubMedCrossRef

71.

Lane NE, Thompson JM. Management of osteoarthritis in the primary-care setting: an evidence based approach to treatment. Am J Med. 1997;103:25S–30S.PubMedCrossRef

72.

Bighetti EJ, Hiruma-Lima CA, Gracioso JS, Arm SB. Anti- inflammatory and antinociceptive effect in redents of the essential oil of Croton Cajucara Benth. J Pharm Pharmacol. 1999;51:1447–53.PubMedCrossRef

73.

Jett MF, Ramesha CS, Brown CD, Chiu S, Emmett C, Voronin T, et al. Characterization of the analgesic and anti-inflammatory activities of ketorolac and its enantiomers in the rat. J Pharmacol Exp Ther. 1999;288:1288–97.PubMed

74.

Gupta PK, Varshney RK, Sharma PC, Ramesh B. Molecular markers and their applications in wheat breeding. Plant Breed. 1999;118:369–90.CrossRef

75.

Parnham MJ. Benefits and risks of the squeezed sap of the purple coneflower (Echinacea purpurea) for long-term oral immunostimulant therapy. In: Wagner H, editor. Immunomodulatory Agents from Plants. Birkhauser, Boston 1999; 119–135.

76.

Martinez A, Anllo-Vento L, Sereno MI, Frank LR, Buxton RB, Dubowitz DJ, et al. Involvement of striate and extrastriate visual cortical areas in spatial attention. Nat Neurosci. 1999;2:364–9.PubMedCrossRef

77.

Wong YF, Zhou H, Wang JR, Xie Y, Xu HX, Liu L. Anti-inflammatory and analgesic effects and molecular mechanisms of JCICM-6, a purified extract derived from an anti-arthritic Chinese herbal formula. Phytomed. 2008;15:416–26.CrossRef

78.

Bauerova K, Bezek A. Role of reactive oxygen and nitrogen species in etiopathogenesis of rheumatoid arthritis. Gen Physiol Biophys. 1999;18:15–20.PubMed

79.

Feldmann M, Brennan FM, Foxwell BM, Maini RN. The role of TNF-alpha and IL-1 in rheumatoid arthritis. Curr Dir Autoimmun. 2001;3:188–99.PubMedCrossRef

80.

Knight JA. Free radicals, antioxidants, and the immune system. Ann Clin Lab Sci. 2000;30:145–58.PubMed

81.

Borel JP, Monboisse JC. Effect of oxygen free radicals on collagen in inflammation. Ann Biol Clin. 1986;44:260–5.

82.

Monboisse JC, Poulin G, Braquet P, Randoux A, Ferradini C, Borel JP. Effect of oxy radicals on several types of collagen. Int J Tissue React. 1984;6:385–90.PubMed

83.

Monboisse JC, Gardes-Albert M, Randoux A, Borel JP, Ferradini C. Collagen degradation by superoxide anion in pulse and gamma radiolysis. Biochim Biophys Acta. 1988;965:29–35.PubMedCrossRef

84.

Iyama S, Okamoto T, Sato T, Yamauchi N, Sato Y, Sasaki K, et al. Treatment of murine collagen-induced arthritis by ex vivo extracellular superoxide dismutase gene transfer. Arthritis Rheum. 2001;44:2160–7.PubMedCrossRef

85.

Salvemini D, Ischiropoulos H, Cuzzocrea S. Roles of nitric oxide and superoxide in inflammation. Methods Mol Biol. 2003;225:291–303.PubMed

86.

Fahim AT, Abd-El Fattah AA, Agha AM, Gad MZ. Effect of pumpkin-seed oil on the level of free radical scavengers induced during adjuvant-arthritis in rats. Pharmacol Res. 1995; 31(1):73–9.

87.

McCord JM. Free radicals and inflammation: protection of synovial fluid by superoxide dismutase. Science. 1974;185:529–31.PubMedCrossRef

88.

Greenwald RA, Moy WW. Effect of oxygen-derived free radicals on hyaluronic acid. Arthritis Rheum. 1980;23:455–63.PubMedCrossRef

Titel: The anti-arthritic and anti-oxidative effect of NBD (6-nitro-1,3-benzodioxane) in adjuvant-induced arthritis (AIA) in rats
verfasst von: Syed Uzair Ali Shah
Nadeem Ashraf
Zahid H. Soomro
Muhammad Raza Shah
Nurul Kabir
Shabana Usman Simjee
Publikationsdatum: 01.08.2012
Verlag: SP Birkhäuser Verlag Basel
Erschienen in: Inflammation Research / Ausgabe 8/2012
Print ISSN: 1023-3830
Elektronische ISSN: 1420-908X
DOI: https://doi.org/10.1007/s00011-012-0480-4

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

25.04.2024 Allergien und Intoleranzreaktionen Nachrichten

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Objectives

Methods

Results

Conclusion

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 8/2012

Use of blood urea nitrogen, creatinine, interleukin-6, granulocyte–macrophage colony stimulating factor in combination to predict the severity and outcome of abdominal sepsis in rats

Association of promoter region single nucleotide polymorphisms at positions −819C/T and −592C/A of interleukin 10 gene with ischemic heart disease

Anti-inflammatory effects of arbutin in lipopolysaccharide-stimulated BV2 microglial cells

Inflammatory markers and bariatric surgery: a meta-analysis

Chronic aspiration shifts the immune response from adaptive immunity to innate immunity in a murine model of asthma